Anti-Hypertensive Drugs Market Competitive Landscape 2024-2033 – Major Players and Strategies

Overview and Scope
Anti-hypertensive drugs refer to a group of medications used to treat high blood pressure (high blood pressure). The goal of antihypertensive therapy is to prevent the negative effects of high blood pressure, such as myocardial infarction and stroke.

Sizing and Forecast
The anti-hypertensive drugs market size has grown steadily in recent years. It will grow from $35.8 billion in 2023 to $36.7 billion in 2024 at a compound annual growth rate (CAGR) of 2.5%.  The  growth in the historic period can be attributed to environmental and lifestyle influences, historical market competition, historical treatment preferences, economic conditions, historical global health trends.

The anti-hypertensive drugs market size is expected to see steady growth in the next few years. It will grow to $40.28 billion in 2028 at a compound annual growth rate (CAGR) of 2.4%.  The growth in the forecast period can be attributed to cost-effectiveness and affordability, emerging therapeutic innovations, epidemiological trends, regulatory changes and approvals, aging population dynamics, healthcare policies and reimbursement changes. Major trends in the forecast period include therapeutic innovation, epidemiological shifts, regulatory landscape, healthcare policies, advancements in diagnosis and monitoring.

Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/anti-hypertensive-drugs-global-market-report

Segmentation & Regional Insights
The anti-hypertensive drugs market covered in this report is segmented –
1) By Therapeutics: Diuretics, Angiotensin Receptor Blockers (ARBs), Angiotensin Converting Enzyme (ACE) Inhibitors, Beta Blockers, Alpha Blockers, Calcium Channel Blockers, Renin Inhibitors, Vasodilators
2) By Disease Source: Primary Hypertension, Secondary Hypertension
3) By End Users: Hospitals, Clinics, Homecare

North America was the largest region in the anti-hypertensive drugs market in 2023. The Middle East is expected to be the largest growing region in the global anti-hypertensive drugs market during the forecast period. The regions covered in the anti-hypertensive drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2410&type=smp

Major Driver Impacting Market Growth
A sedentary lifestyle is a major driver of the growth of the anti-hypertensive drug market. Consumption of junk food, lack of proper healthy and balanced diet, and lack of proper sleep due to irregular work shifts have contributed to the increase in hypertension. Hypertension is the underlying factor for at least 45% of deaths due to heart disease and 51% of deaths due to stroke. Once the patient is diagnosed with hypertension, patients are required to use the drugs to control hypertension based on the severity of the condition. Furthermore, in June 2021, according to the World Health Organization data 2021, a Switzerland-based Government agency responsible for international public health, cardiovascular diseases (CVDs) are the leading cause of death globally, taking an estimated 17.9 million lives each year. This creates a sustainable demand for the product and acts as a prominent driver for the growth of the market.

Key Industry Players
Major companies operating in the anti-hypertensive drugs market report are Pfizer Inc., Johnson & Johnson Ltd., F. Hoffmann-La Roche Ltd, Merck & Co. Inc., AbbiVe Inc., Bayer AG, Novartis AG, Sanofi SA, Astra Zeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., C.H. Boehringer Sohn AG & Ko. KG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Daiichi Sankyo Company Limited, Fresenius Kabi AG, Sun Pharmaceuticals LLC, Cipla Limited, Dr. Reddy's Laboratories, Hikma Pharmaceuticals PLC, Lupin Limited, United Therapeutics, Torrent Pharmaceuticals Ltd, Ranbaxy Laboratories, Noden Pharma DAC, Acacia Pharma Group Plc, Actelion Pharmaceuticals Ltd.

The anti-hypertensive drugs market report table of contents includes:
1. Executive Summary
2. Anti-Hypertensive Drugs Market Characteristics
3. Anti-Hypertensive Drugs Market Trends And Strategies
4. Anti-Hypertensive Drugs Market - Macro Economic Scenario
5. Global Anti-Hypertensive Drugs Market Size and Growth
……………….
32. Global Anti-Hypertensive Drugs Market Competitive Benchmarking
33. Global Anti-Hypertensive Drugs Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Anti-Hypertensive Drugs Market
35. Anti-Hypertensive Drugs Market Future Outlook and Potential Analysis
36. Appendix